| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 12 | 2014 | 43 | 2.260 |
Why?
|
| Cardiology | 12 | 2022 | 48 | 2.190 |
Why?
|
| Ventricular Outflow Obstruction | 4 | 2015 | 12 | 1.300 |
Why?
|
| Heart Atria | 6 | 2011 | 177 | 1.040 |
Why?
|
| Education, Medical, Graduate | 8 | 2020 | 119 | 1.010 |
Why?
|
| Chest Pain | 4 | 2015 | 26 | 0.980 |
Why?
|
| Clinical Competence | 9 | 2022 | 249 | 0.950 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 384 | 0.920 |
Why?
|
| Pulmonary Veins | 4 | 2014 | 108 | 0.860 |
Why?
|
| Sinus of Valsalva | 2 | 2015 | 13 | 0.850 |
Why?
|
| Aortic Aneurysm | 3 | 2015 | 16 | 0.850 |
Why?
|
| Echocardiography | 7 | 2013 | 110 | 0.850 |
Why?
|
| Aneurysm, Ruptured | 2 | 2015 | 20 | 0.840 |
Why?
|
| Pulmonary Artery | 3 | 2014 | 69 | 0.800 |
Why?
|
| Catheter Ablation | 5 | 2015 | 223 | 0.740 |
Why?
|
| Internship and Residency | 4 | 2020 | 263 | 0.670 |
Why?
|
| Atrial Fibrillation | 4 | 2011 | 405 | 0.650 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2016 | 3 | 0.620 |
Why?
|
| Physicians | 5 | 2022 | 83 | 0.610 |
Why?
|
| Heart Defects, Congenital | 2 | 2013 | 96 | 0.600 |
Why?
|
| Humans | 58 | 2022 | 29202 | 0.590 |
Why?
|
| Societies, Medical | 3 | 2022 | 93 | 0.590 |
Why?
|
| Thrombosis | 3 | 2013 | 155 | 0.530 |
Why?
|
| Specialty Boards | 1 | 2017 | 11 | 0.530 |
Why?
|
| Competency-Based Education | 1 | 2017 | 18 | 0.520 |
Why?
|
| Internal Medicine | 1 | 2017 | 30 | 0.520 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2012 | 5 | 0.520 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2013 | 9 | 0.490 |
Why?
|
| Employment | 1 | 2016 | 49 | 0.490 |
Why?
|
| Coronary Vessels | 2 | 2012 | 154 | 0.470 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 35 | 0.460 |
Why?
|
| Stroke | 3 | 2015 | 261 | 0.440 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 8 | 0.420 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 41 | 0.420 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2013 | 173 | 0.420 |
Why?
|
| Prosthesis-Related Infections | 1 | 2014 | 14 | 0.420 |
Why?
|
| Device Removal | 1 | 2014 | 30 | 0.420 |
Why?
|
| Heart Diseases | 4 | 2015 | 71 | 0.410 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 126 | 0.410 |
Why?
|
| Arteriovenous Malformations | 1 | 2014 | 16 | 0.410 |
Why?
|
| Chordae Tendineae | 1 | 2013 | 11 | 0.410 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 32 | 0.410 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 16 | 0.400 |
Why?
|
| Mitral Valve | 1 | 2013 | 63 | 0.390 |
Why?
|
| Male | 28 | 2020 | 14120 | 0.390 |
Why?
|
| Hospitals, Teaching | 4 | 2003 | 26 | 0.390 |
Why?
|
| Hypoxia | 1 | 2014 | 90 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 84 | 0.380 |
Why?
|
| Heart Neoplasms | 2 | 2007 | 17 | 0.380 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 26 | 0.380 |
Why?
|
| Treatment Outcome | 9 | 2014 | 2442 | 0.370 |
Why?
|
| Middle Aged | 22 | 2015 | 7493 | 0.370 |
Why?
|
| Brain Ischemia | 1 | 2013 | 88 | 0.360 |
Why?
|
| Ultrasonography | 4 | 2015 | 244 | 0.350 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 16 | 0.350 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 98 | 0.330 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2010 | 4 | 0.330 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2010 | 2 | 0.320 |
Why?
|
| Pulmonary Valve | 1 | 2010 | 14 | 0.310 |
Why?
|
| Heart Failure | 2 | 2010 | 254 | 0.310 |
Why?
|
| Postoperative Complications | 5 | 2010 | 643 | 0.300 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2010 | 64 | 0.300 |
Why?
|
| Mentors | 3 | 2019 | 40 | 0.300 |
Why?
|
| Female | 19 | 2020 | 15819 | 0.290 |
Why?
|
| Heart Failure, Systolic | 1 | 2008 | 3 | 0.280 |
Why?
|
| Electrocardiography | 5 | 2008 | 398 | 0.280 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 13 | 0.280 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 49 | 0.270 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2008 | 29 | 0.270 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 380 | 0.270 |
Why?
|
| Fibroma | 1 | 2007 | 6 | 0.270 |
Why?
|
| Endocarditis, Bacterial | 1 | 2007 | 15 | 0.260 |
Why?
|
| Reoperation | 4 | 2013 | 159 | 0.260 |
Why?
|
| United States | 9 | 2022 | 2269 | 0.260 |
Why?
|
| Cardiology Service, Hospital | 2 | 1997 | 6 | 0.250 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 90 | 0.240 |
Why?
|
| Career Choice | 2 | 2017 | 53 | 0.230 |
Why?
|
| Adult | 13 | 2015 | 8125 | 0.230 |
Why?
|
| Coronary Disease | 3 | 2008 | 120 | 0.220 |
Why?
|
| Follow-Up Studies | 8 | 2009 | 1033 | 0.220 |
Why?
|
| Risk Assessment | 3 | 2013 | 632 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 435 | 0.210 |
Why?
|
| Advisory Committees | 2 | 2015 | 33 | 0.210 |
Why?
|
| Work Schedule Tolerance | 1 | 2003 | 11 | 0.200 |
Why?
|
| Aged | 12 | 2015 | 5647 | 0.190 |
Why?
|
| Workload | 1 | 2003 | 44 | 0.190 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2003 | 45 | 0.190 |
Why?
|
| Medicine | 1 | 2022 | 22 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2022 | 21 | 0.180 |
Why?
|
| Coronary Artery Disease | 3 | 2013 | 220 | 0.180 |
Why?
|
| Myocardial Infarction | 3 | 1998 | 351 | 0.180 |
Why?
|
| Faculty, Medical | 2 | 2019 | 60 | 0.170 |
Why?
|
| American Heart Association | 3 | 2022 | 21 | 0.170 |
Why?
|
| Academic Medical Centers | 3 | 2014 | 79 | 0.160 |
Why?
|
| Education | 1 | 2020 | 33 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 42 | 0.160 |
Why?
|
| Comorbidity | 2 | 2011 | 261 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 2 | 1997 | 14 | 0.160 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2022 | 96 | 0.150 |
Why?
|
| Patient Care Team | 2 | 1997 | 66 | 0.150 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2013 | 291 | 0.150 |
Why?
|
| Professionalism | 1 | 2019 | 7 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2010 | 123 | 0.140 |
Why?
|
| Telemetry | 1 | 1998 | 8 | 0.140 |
Why?
|
| Erythropoietin | 1 | 1998 | 12 | 0.140 |
Why?
|
| Monitoring, Ambulatory | 1 | 1998 | 26 | 0.140 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1998 | 16 | 0.140 |
Why?
|
| Varicose Veins | 1 | 1998 | 3 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 1998 | 50 | 0.140 |
Why?
|
| Education, Medical | 1 | 2019 | 71 | 0.140 |
Why?
|
| Pigmentation Disorders | 1 | 1997 | 8 | 0.140 |
Why?
|
| Amiodarone | 1 | 1997 | 11 | 0.140 |
Why?
|
| Cardiologists | 1 | 2017 | 3 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 1998 | 43 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 1998 | 44 | 0.130 |
Why?
|
| Curriculum | 2 | 2016 | 307 | 0.130 |
Why?
|
| Hospital Units | 1 | 1997 | 4 | 0.130 |
Why?
|
| Case Management | 1 | 1997 | 11 | 0.130 |
Why?
|
| Job Description | 1 | 2016 | 3 | 0.130 |
Why?
|
| Interinstitutional Relations | 1 | 1996 | 11 | 0.130 |
Why?
|
| Coronary Circulation | 1 | 1997 | 30 | 0.130 |
Why?
|
| Hospitals, Veterans | 4 | 1997 | 22 | 0.130 |
Why?
|
| Family Practice | 1 | 1997 | 47 | 0.130 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 1996 | 2 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 485 | 0.120 |
Why?
|
| Decision Making | 1 | 1998 | 179 | 0.120 |
Why?
|
| Patient Transfer | 1 | 1996 | 43 | 0.120 |
Why?
|
| Catheterization, Central Venous | 1 | 1996 | 38 | 0.120 |
Why?
|
| Esophagus | 1 | 1997 | 72 | 0.120 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 1996 | 14 | 0.120 |
Why?
|
| Reflex | 1 | 1997 | 74 | 0.120 |
Why?
|
| Time Factors | 3 | 2010 | 1619 | 0.120 |
Why?
|
| Certification | 1 | 2015 | 16 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2017 | 467 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 1996 | 64 | 0.110 |
Why?
|
| Electric Countershock | 1 | 2015 | 29 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 11 | 0.110 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 13 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1995 | 79 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 1995 | 103 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2010 | 221 | 0.110 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2014 | 8 | 0.100 |
Why?
|
| Risk Factors | 3 | 2013 | 2144 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 177 | 0.100 |
Why?
|
| Heart Septum | 1 | 2013 | 17 | 0.100 |
Why?
|
| Systole | 1 | 2013 | 24 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 99 | 0.100 |
Why?
|
| Motion | 1 | 2013 | 27 | 0.100 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 2070 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2013 | 43 | 0.100 |
Why?
|
| Myocardial Reperfusion | 1 | 2013 | 5 | 0.100 |
Why?
|
| Heart Conduction System | 2 | 2009 | 270 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 56 | 0.100 |
Why?
|
| Registries | 1 | 2015 | 399 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 114 | 0.100 |
Why?
|
| Incidence | 2 | 2015 | 580 | 0.100 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 52 | 0.100 |
Why?
|
| African Americans | 1 | 2015 | 353 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 237 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 415 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2014 | 302 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 817 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 66 | 0.080 |
Why?
|
| Oklahoma | 4 | 2000 | 1063 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 1021 | 0.080 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2010 | 2 | 0.080 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 13 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 613 | 0.080 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 8 | 0.080 |
Why?
|
| Embolism | 1 | 1989 | 14 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 81 | 0.070 |
Why?
|
| Cardiac Volume | 1 | 2008 | 7 | 0.070 |
Why?
|
| Atrial Function, Left | 1 | 2008 | 4 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 21 | 0.070 |
Why?
|
| Cardiac Output | 1 | 2008 | 36 | 0.070 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 42 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 44 | 0.070 |
Why?
|
| Acute Disease | 1 | 2008 | 157 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 64 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 225 | 0.070 |
Why?
|
| Papillary Muscles | 1 | 2007 | 15 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 48 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 44 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2008 | 125 | 0.070 |
Why?
|
| Aortic Valve | 2 | 1998 | 92 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 149 | 0.060 |
Why?
|
| Hypertension | 2 | 2008 | 309 | 0.060 |
Why?
|
| Young Adult | 1 | 2014 | 2875 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 466 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 468 | 0.060 |
Why?
|
| Amyloidosis | 1 | 1985 | 9 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 1985 | 34 | 0.060 |
Why?
|
| Occupational Health | 1 | 2003 | 13 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 540 | 0.050 |
Why?
|
| Fatigue | 1 | 2003 | 66 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2003 | 84 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 121 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 1998 | 150 | 0.040 |
Why?
|
| Prejudice | 1 | 2020 | 10 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2020 | 19 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 2000 | 9 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2000 | 15 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 92 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 99 | 0.040 |
Why?
|
| Calciphylaxis | 1 | 1998 | 4 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 21 | 0.040 |
Why?
|
| Leadership | 1 | 2019 | 58 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 40 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1998 | 53 | 0.030 |
Why?
|
| Myocardium | 2 | 1998 | 197 | 0.030 |
Why?
|
| Coronary Aneurysm | 1 | 1997 | 2 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2019 | 142 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 1998 | 70 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 11 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 1997 | 19 | 0.030 |
Why?
|
| Dobutamine | 1 | 1997 | 7 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1997 | 28 | 0.030 |
Why?
|
| Comprehensive Health Care | 1 | 1997 | 12 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1997 | 68 | 0.030 |
Why?
|
| Biopsy | 1 | 1998 | 213 | 0.030 |
Why?
|
| Patient Admission | 1 | 1997 | 30 | 0.030 |
Why?
|
| Cost Control | 1 | 1997 | 9 | 0.030 |
Why?
|
| Utilization Review | 1 | 1997 | 10 | 0.030 |
Why?
|
| Schools, Medical | 1 | 1997 | 46 | 0.030 |
Why?
|
| Transfer Agreement | 1 | 1996 | 1 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 1997 | 7 | 0.030 |
Why?
|
| Time Management | 1 | 1996 | 3 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 30 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 1996 | 8 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 1996 | 12 | 0.030 |
Why?
|
| Patient Discharge | 1 | 1997 | 111 | 0.030 |
Why?
|
| Exercise Test | 1 | 1997 | 249 | 0.030 |
Why?
|
| Inservice Training | 1 | 1996 | 10 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 1996 | 22 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 97 | 0.030 |
Why?
|
| Patient Readmission | 1 | 1997 | 108 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 1997 | 84 | 0.030 |
Why?
|
| Length of Stay | 1 | 1997 | 248 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 1996 | 63 | 0.030 |
Why?
|
| Students, Medical | 1 | 1997 | 102 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2008 | 2659 | 0.030 |
Why?
|
| Credentialing | 1 | 2015 | 7 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2015 | 69 | 0.030 |
Why?
|
| Texas | 1 | 1996 | 140 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 1996 | 60 | 0.030 |
Why?
|
| Azathioprine | 1 | 1975 | 7 | 0.030 |
Why?
|
| Polyneuropathies | 1 | 1975 | 3 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2015 | 48 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 77 | 0.030 |
Why?
|
| Stents | 1 | 2015 | 121 | 0.030 |
Why?
|
| Teaching | 1 | 2015 | 84 | 0.030 |
Why?
|
| Pregnancy | 1 | 1998 | 1261 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 191 | 0.030 |
Why?
|
| Foundations | 1 | 2013 | 4 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 54 | 0.020 |
Why?
|
| Consensus | 1 | 2013 | 76 | 0.020 |
Why?
|
| Research Report | 1 | 2013 | 23 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2000 | 484 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 130 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 58 | 0.020 |
Why?
|
| Ganglia, Autonomic | 1 | 2009 | 55 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 236 | 0.020 |
Why?
|
| Heparin | 1 | 1989 | 116 | 0.020 |
Why?
|
| Warfarin | 1 | 1989 | 94 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 13 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Polysomnography | 1 | 2008 | 48 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 73 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 33 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2008 | 77 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 210 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 414 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 56 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1989 | 1287 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1984 | 62 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2000 | 16 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2000 | 28 | 0.010 |
Why?
|
| Back Pain | 1 | 2000 | 21 | 0.010 |
Why?
|
| Leg | 1 | 2000 | 134 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2000 | 124 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1998 | 69 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1998 | 60 | 0.010 |
Why?
|
| Atropine | 1 | 1997 | 47 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1997 | 117 | 0.010 |
Why?
|
| Physical Examination | 1 | 1977 | 53 | 0.010 |
Why?
|
| Aneurysm, Dissecting | 1 | 1996 | 12 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 1996 | 62 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2000 | 845 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1984 | 139 | 0.000 |
Why?
|